Neutrophil-to-albumin Ratio as a Prognostic Factor in Patients with Acute Ischemic Stroke
Authors:
Open Access
- 1 August 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 21 (3) , 300-309
Abstract
Background: Neutrophil-To-Albumin Ratio (NAR) is a novel inflammatory biomarker. However, the potential prognostic value of NAR in acute ischemic stroke (AIS) remains unclear. This study aimed to evaluate whether NAR levels correlated with the 3-month modified Rankin scale (mRS) in patients with AIS. Methods: AIS patients were included in this retrospective study. NAR was calculated as the ratio of absolute neutrophil count to serum albumin level. Logistic regression analyses were used to investigate the effect of NAR on 3-month mRS of AIS. The predictive values of NAR, albumin level, and neutrophil count were compared utilizing receiver operating characteristic (ROC) curves. Moreover, subgroup analyses and interaction tests were conducted to evaluate the consistency of NAR’s effect on AIS prognosis. Results: Of the 780 patients included, 403 (51.67%) had a poor clinical outcome (mRS 3-6) at 3 months. NAR was independently correlated to 3-month poor functional outcome after adjusting for confounders (Odds ratios (OR), 9.34; 95% confidence intervals (CI), 1.09 to 80.13; p =0.0417). Subgroup analysis showed a relative effect consistent with the overall population results, and no statistical interactions were found in the subgroups (all p for interaction > 0.05). The ROC curve showed that the prognosis-related cutoff value for NAR was 0.123, with corresponding specificity and sensitivity of 53.55% and 63.94%, respectively. When comparing the predictive power, NAR (0.590; 95%CI 0.549–0.630) exhibited the highest area under the curve (AUC) of ROC compared to neutrophils (0.584; 95%CI 0.543–0.624) and albumin (0.540; 95%CI 0.500–0.581). Conclusion: There is a positive relationship between NAR levels and 3-month poor functional outcomes in AIS patients, supporting the potential of NAR as a readily available and economic serum biomarker for the early identification of AIS prognosis. Further studies are required to validate the prognostic value and clinical utility of the NAR.Keywords
This publication has 41 references indexed in Scilit:
- Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke TheranosticsAdvanced Science, 2024
- Neutrophil-to-albumin ratio as a novel marker predicting unfavorable outcome in aneurysmal subarachnoid hemorrhageJournal of Clinical Neuroscience, 2022
- Neutrophil Extracellular Traps Exacerbate Ischemic Brain DamageMolecular Neurobiology, 2021
- Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2020
- Blood Biomarkers for Stroke Diagnosis and ManagementNeuroMolecular Medicine, 2019
- Favorable Functional Recovery in Overweight Ischemic Stroke Survivors: Findings from the China National Stroke RegistryJournal of Stroke and Cerebrovascular Diseases, 2014
- Cortisol levels and the severity and outcomes of acute stroke: a systematic reviewJournal of Neurology, 2014
- Serum albumin as a determinant of cortisol release in patients with acute ischemic strokeAtherosclerosis, 2012
- Ischemic stroke in the elderly: an overview of evidenceNature Reviews Neurology, 2010
- Malnutrition determined by the patient-generated subjective global assessment is associated with poor outcomes in acute stroke patientsClinical Nutrition, 2005